{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T19:25:08Z","timestamp":1790018708550,"version":"4.0.1"},"reference-count":10,"publisher":"American Association for Cancer Research (AACR)","issue":"13","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7,2]]},"abstract":"<jats:p>ARF (p14ARF) is a tumor suppressor classically known for stabilizing and activating p53. In this issue of Cancer Research, Ferreira and colleagues provide insights into the role of ARF in the development of pancreatic ductal adenocarcinoma, showing its p53-independent tumor microenvironment regulatory function. The findings reveal a significant association of ARF loss with stromal remodeling characterized by increased extracellular matrix deposition and fibroblast infiltration. Although further studies are needed to explore the underlying mechanisms and to determine clinical significance, this study has highlighted ARF as a potential upstream regulator of the microenvironment and a candidate therapeutic target.<\/jats:p>\n                  <jats:p>See related article by Ferreira et al., p. 3109<\/jats:p>","DOI":"10.1158\/0008-5472.can-26-2014","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T07:09:49Z","timestamp":1782976189000},"page":"3101-3102","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["ARF beyond p53: Shaping the Pancreatic Tumor Microenvironment"],"prefix":"10.1158","volume":"86","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3804-6712","authenticated-orcid":false,"given":"Eliana","family":"Destefanis","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02smfhw86","id-type":"ROR","asserted-by":"publisher"}],"name":"Virginia Tech 1 FBRI Cancer Research Center, Fralin Biomedical Research Institute, , Washington, District of Columbia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3436-8239","authenticated-orcid":false,"given":"Kathleen M.","family":"Mulvaney","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02smfhw86","id-type":"ROR","asserted-by":"publisher"}],"name":"Virginia Tech 1 FBRI Cancer Research Center, Fralin Biomedical Research Institute, , Washington, District of Columbia."},{"id":[{"id":"https:\/\/ror.org\/02smfhw86","id-type":"ROR","asserted-by":"publisher"}],"name":"Virginia Tech 2 Department of Biomedical Sciences and Pathobiology, , Blacksburg, Virginia."},{"name":"3Center for Cancer and Immunology Research, Children\u2019s National Hospital, Washington, District of Columbia."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2026,7,1]]},"reference":[{"key":"2026070203094079400_bib1","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J Clin"},{"key":"2026070203094079400_bib2","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"2026070203094079400_bib3","first-page":"e70035","article-title":"Advances in pancreatic cancer early diagnosis, prevention, and treatment: the past, the present, and the future","volume":"76","author":"Mannucci","year":"2026","journal-title":"CA Cancer J Clin"},{"key":"2026070203094079400_bib4","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ccell.2017.07.007","article-title":"Integrated genomic characterization of pancreatic ductal adenocarcinoma","volume":"32","author":"Cancer Genome Atlas Research Network","year":"2017","journal-title":"Cancer Cell"},{"key":"2026070203094079400_bib5","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/s41698-024-00681-z","article-title":"Barriers and opportunities in pancreatic cancer immunotherapy","volume":"8","author":"Ju","year":"2024","journal-title":"NPJ Precis Oncol"},{"key":"2026070203094079400_bib6","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1158\/0008-5472.CAN-25-1969","article-title":"Inactivation of CDKN2AARF promotes p53-independent remodeling of the PDAC tumor microenvironment","volume":"86","author":"Ferreira","year":"2026","journal-title":"Cancer Res"},{"key":"2026070203094079400_bib7","doi-asserted-by":"crossref","first-page":"5947","DOI":"10.1073\/pnas.0601273103","article-title":"Both p16(Ink4a) and the p19(Arf)-p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse","volume":"103","author":"Bardeesy","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026070203094079400_bib8","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1158\/1541-7786.MCR-10-0475","article-title":"The ARF tumor suppressor inhibits tumor cell colonization independent of p53 in a novel mouse model of pancreatic ductal adenocarcinoma metastasis","volume":"9","author":"Muniz","year":"2011","journal-title":"Mol Cancer Res"},{"key":"2026070203094079400_bib9","doi-asserted-by":"crossref","first-page":"e12454","DOI":"10.1371\/journal.pone.0012454","article-title":"Loss of p19(Arf) facilitates the angiogenic switch and tumor initiation in a multi-stage cancer model via p53-dependent and independent mechanisms","volume":"5","author":"Ulanet","year":"2010","journal-title":"PLoS One"},{"key":"2026070203094079400_bib10","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1038\/s41467-024-46048-7","article-title":"Plasticity-induced repression of Irf6 underlies acquired resistance to cancer immunotherapy in pancreatic ductal adenocarcinoma","volume":"15","author":"Kim","year":"2024","journal-title":"Nat Commun"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/86\/13\/3101\/3806146\/can-26-2014.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/86\/13\/3101\/3806146\/can-26-2014.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T07:09:51Z","timestamp":1782976191000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/86\/13\/3101\/786146\/ARF-beyond-p53-Shaping-the-Pancreatic-Tumor"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":10,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2026,7,1]]},"published-print":{"date-parts":[[2026,7,2]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-26-2014","relation":{},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,1]]}}}